(PDF) P2.13-28 Comparison of ddPCR and NGS in Liquid Biopsy

P2.13-28 Comparison of ddPCR and NGS in Liquid Biopsy to Pathology Results in EGFR-Mutated NSCLC

Journal of Thoracic Oncology - United States

doi 10.1016/j.jtho.2018.08.1423

Full Text

Abstract

Available in full text

Categories

Respiratory Medicine

Date

October 1, 2018

Authors

E. Oomen - De Hoop

J. Von Der Thüsen

Publisher

Elsevier BV

Related search

P2.13-14 the Clinical Usefulness of Liquid Biopsy for Detection and Dynamic Monitoring of EGFR T790M in NSCLC Patients on EGFR-TKI Therapy

Journal of Thoracic Oncology

Respiratory Medicine

English

P3.02-038 Diagnosis of Leptomeningeal Disease and Clonal Heterogeneity With Digital Droplet PCR (ddPCR) in EGFR Mutated NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.13-13 Real-World Study of Osimertinib in EGFR T790m-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.13-26 Impact of Concurrent Tumor Suppressor Gene Mutation on Clinical Outcomes in EGFR Mutated NSCLC Treated With First-Line TKI

Journal of Thoracic Oncology

Respiratory Medicine

English

Liquid Biopsy Holds Its Own in NSCLC

Cancer Discovery

English

P2.13-16 Preference of Adjuvant Treatments for EGFR-Mutant Resected NSCLC Patients: Results of a National-Wide Survey in China

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.01-06 HSP72 Expression Associates With Survival in EGFR Mutated NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

MA18.09 Predictors of Health Utility Scores (HUS) in Advanced EGFR-Mutated NSCLC

Journal of Thoracic Oncology

Respiratory Medicine

English

Trastuzumab Emtansine Delays and Overcomes Resistance to the Third-Generation EGFR-TKI Osimertinib in NSCLC EGFR Mutated Cell Lines

Journal of Experimental and Clinical Cancer Research

Cancer Research

English